Hematologic NeoplasmsLeukemiaGeotrichosisImmunocompromised HostAspergillosisLymphomaMultiple MyelomaNeoplasmsAntineoplastic AgentsGeotrichumNeutropeniaChemotherapy-Induced Febrile NeutropeniaMycosesEndosulfanAntifungal AgentsMannansHematopoietic Stem Cell TransplantationHematologyPrecursor Cell Lymphoblastic Leukemia-LymphomaOpportunistic InfectionsTransplantation, HomologousLymphoma, Non-HodgkinLeukemia, Myeloid, AcuteGraft vs Host DiseaseLung Diseases, FungalTransplantation ConditioningBone Marrow TransplantationHematologic DiseasesRetrospective StudiesTreatment OutcomeFungemiaPyomyositisLeukemia, Myelomonocytic, AcuteZygomycosisCord Blood Stem Cell TransplantationFeverMucormycosisLeukemia, B-CellMyelodysplastic SyndromesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Lymphocytic, Chronic, B-CellAmphotericin BFatal OutcomePyrazinesBacteremiaVidarabineAgranulocytosisPyrimidinesHodgkin DiseaseTransplantation, AutologousPrognosisAspergillusCell Line, TumorSensitivity and SpecificityStem Cell TransplantationTumor Cells, CulturedMinor Histocompatibility AntigensChromosomes, Human, Pair 12Flow CytometryEchinocandinsLymphoproliferative DisordersBoronic AcidsBone MarrowSurvival AnalysisTriazolesImmunophenotypingGene Expression Regulation, NeoplasticRecurrenceLymphoma, B-CellItraconazoleClinical Trials as TopicApoptosisProspective StudiesK562 CellsDNA MethylationGraft SurvivalLeukemia, MyeloidIncidenceAntibiotic ProphylaxisGene Expression Regulation, LeukemicCandidiasisTime FactorsTranslocation, GeneticImmunotherapyNeoplasm ProteinsAntibodies, MonoclonalDose-Response Relationship, DrugTumor Markers, BiologicalHistocompatibility TestingBenzamidesPiperazinesSurvival RateHematopoietic Stem CellsInfectionAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyCell ProliferationDrug Resistance, NeoplasmSignal TransductionRisk Factors